Monday, December 7th, 2020

The National Center for Precision Diabetic Medicine and PreciDIAB Initiative, are organising a one-day networking meeting: public-private and private-private partnerships in the field of diabetes and comorbidities. PreciDIAB Initiative is the business club of PreciDIAB. More information:


  • To take part in PreciDIAB Meeting, you must be registered for BioFIT event
  • Registration to PreciDIAB Meeting is free but mandatory


9:00-10:00 AM CET

PreciDIAB Academia-Industry R&D Collaborations

PreciDIAB is creating favourable conditions for efficient Public/Private collaborative research (diagnosis and follow-up tools, drugs, medical and IT devices), and setting up a comprehensive “machinery” to generate scientific outcomes and exploit them smoothly.

  • Introducing PreciDIAB, Professor Philippe Froguel
  • Collaborative success stories
    • Medical device clinical evaluation, Professor Robert Caiazzo
    • Medical diagnosis, Dr Amélie Bonnefond


  • Matthias Vandesquille, Project Manager – PreciDIAB National Center
  • Xavier Martin Benlloch, Technology Transfer Officer, Eurasanté

12:00–1:00 PM CET

PreciDIAB Kick-Off Program – Journalists Invited        

Industrial Chair                                                                                                                             

Development of innovative oligonucleotide-based treatments targeting miRNAs for human obesity, type 2 diabetes, non-alcoholic fatty liver disease and associated cardio-metabolic disorders.

Introducing METABOMIR, Dr Jean-Sébastien AnnicotteLille University & Marc ThibonnierAPTAMIR EUROPE


  • Gilles Pulvermuller, General Secretary of EGID (European Genomic Institute for Diabetes)
  • Ségolène Lebrun, Biotechnology Advisor, Clubster Nutrition Health Longevity


The Acceleration Program by Eurasanté launches the call DIABETES & METABOLIC DISEASES ACCELERATION PROJECTS.

Open to challenging bioentrepreneurs, start-ups, SMEs willing to shorten the time-to-market of their projects and penetrate the European health market: fast-track connections with PreciDIAB network, investors network, and a tailor-made support from the Eurasanté team.

Introducing the call: 

  • Rémi Verstraete, Start-up advisor, Eurasanté
  • Caroline Ramspacher, Innovation & Entrepreneurship Partner, Eurasanté

2:30–3:15 PM CET

PreciDIAB Networking group:

Horizon Europe: What is new?
Virginie Sivan
, French Delegate for program Committees in H2020 (health, ERC, FET)


  • Julien Holgard, European Project Officer, Eurasanté
  • Gaylord Bauden Hamerel, Innovation Project Manager, Eurasanté